Mode
Text Size
Log in / Sign up
N/A Completed N=103,048 Randomized Double-blind Health Services Research

Pragmatic Trial of Video Education in Nursing Homes

Alzheimer's Disease · Dementia · Heart Failure · Pulmonary Disease, Chronic Obstructive
Source: ClinicalTrials.gov NCT02612688 ↗
Enrolled (actual)
103,048
Serious AEs
0.0%
Results posted
Jun 2020
Primary outcomePrimary: Hospital Transfer Rate in Target Cohort — 2.4; 2.8 person-years

Summary

This is a pragmatic cluster-randomized control trial (RCT) of an Advance Care Planning (ACP) Video Program for nursing home (NH) patients ≥ 65 years old who are cared for in 360 NH facilities (intervention arm n=119; control arm n=241) within two NH health care systems: Genesis HealthCare and PruittHealth. The intervention NH facilities will implement the ACP Video Program, while the control NH facilities will follow their usual ACP procedures. The trial will evaluate the effectiveness of the ACP Video Program by comparing hospitalizations, advance directives, and hospice use in the intervention vs. control NHs.

Outcome Measures

OutcomeResultp-value
PRIMARY
Hospital Transfer Rate in Target Cohort
2.4; 2.8
SECONDARY
Hospital Transfer Rate Among Long-stay Residents Without Advanced Illness
1.65; 1.68
SECONDARY
Hospital Transfer Rate Among Short-stay Residents With Advanced Illness
6.9; 6.8
SECONDARY
Hospital Transfer Rate Among Short-stay Residents Without Advanced Illness
4.5; 4.4
SECONDARY
Proportion of Target Cohort With Last Observed Advance Directive Status
295; 570; 1288; 2010; 387; 300
SECONDARY
Proportion of Long-stay Residents Without Advanced Illness With Last Observed Advance Directive Status
1150; 2210; 1714; 3018; 369; 431
SECONDARY
Proportion of Short-stay Residents With Advanced Illness With Last Observed Advance Directive Status
482; 761; 581; 858; 103; 82
SECONDARY
Proportion of Short-stay Residents Without Advanced Illness With Last Observed Advance Directive Status
8289; 12899; 4541; 6392; 462; 493
SECONDARY
Proportion of Target Cohort Receiving Any Burdensome Treatment
453; 971
SECONDARY
Proportion of Long-stay Residents Without Advanced Illness Receiving Any Burdensome Treatment
465; 1028
SECONDARY
Proportion of Short-stay Residents With Advanced Illness Receiving Any Burdensome Treatment
294; 621
SECONDARY
Proportion of Short-stay Residents Without Advanced Illness Receiving Any Burdensome Treatment
1726; 3405
SECONDARY
Proportion of Target Cohort With Any Hospice Enrollment
904; 1878
SECONDARY
Proportion of Long-stay Residents Without Advanced Illness With Any Hospice Enrollment
373; 832
SECONDARY
Proportion of Short-stay Residents With Advanced Illness With Any Hospice Enrollment
588; 1220
SECONDARY
Proportion of Short-stay Residents Without Advanced Illness With Any Hospice Enrollment
2273; 4875
SECONDARY
Proportion of Target Cohort That Has Medicare ACP Billing Codes
356; 685
SECONDARY
Proportion of Long-stay Residents Without Advanced Illness That Has Medicare ACP Billing Codes
571; 1157
SECONDARY
Proportion of Short-stay Residents With Advanced Illness That Has Medicare ACP Billing Codes
224; 479
SECONDARY
Proportion of Short-stay Residents Without Advanced Illness That Has Medicare ACP Billing Codes
1669; 4068

Eligibility Criteria

Inclusion Criteria

  • Facilities are within Genesis HealthCare or PruittHealth health care systems
  • Facilities have facility identifiers that indicate that they are Medicare/Medicaid-certified nursing facilities in the U.S.
  • Facilities serve both short and long-stay patients
  • Facilities have >50 beds
  • Facilities have an electronic medical records system
  • Facilities had at least 20 admissions and 20 annual Minimum Data Set (MDS) assessments (regardless of whether they were discharged alive) in 2013

Exclusion Criteria

  • Facilities excluded per corporate leaders in health care system because of recent turnover in NH administrator or Director of Nursing
  • Facilities excluded per corporate leaders in health care system because of recent bad state or federal quality assurance survey (e.g. restriction on admissions, levied large civil monetary penalty, etc.)
  • Facilities excluded per corporate leaders in health care system because of current new initiatives/competing demands
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02612688). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search